Ammon B. Peck
Direttore Tecnico/Scientifico/R&S presso Ixion Biotechnology, Inc.
Profilo
Ammon B.
Peck co-founded Ixion Biotechnology, Inc. in 1995 and currently serves as Chief Scientific Officer and Senior Vice President.
He is a Professor of Pathology and Laboratory Medicine at the University of Florida.
Posizioni attive di Ammon B. Peck
| Società | Posizione | Inizio |
|---|---|---|
Ixion Biotechnology, Inc.
 Ixion Biotechnology, Inc. BiotechnologyHealth Technology Ixion Biotechnology, Inc. develops somatic cellular therapies to treat diabetes. The company was founded by Weaver H. Gaines and David C. Peck on April 4, 1994 and is headquartered in Alachua, FL. | Direttore Tecnico/Scientifico/R&S | 01/01/1995 |
| University of Florida | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Ixion Biotechnology, Inc.
Ixion Biotechnology, Inc. BiotechnologyHealth Technology Ixion Biotechnology, Inc. develops somatic cellular therapies to treat diabetes. The company was founded by Weaver H. Gaines and David C. Peck on April 4, 1994 and is headquartered in Alachua, FL. | Health Technology |
- Borsa valori
- Insiders
- Ammon B. Peck
